期刊文献+

pcDNA3.1-mTOR质粒体外转染对乳腺癌细胞生长的影响 被引量:4

Effect of mTOR plasmid transfection on growth of breast cancer MCF-7 cells in vitro
下载PDF
导出
摘要 目的研究信号转导通路m TOR体外对乳腺癌MCF-7细胞生长的抑制作用,及对抑癌基因PTEN的负反馈调节的影响。方法用pc DNA3.1-m TOR真核表达质粒及空载质粒转染MCF-7;Western blot检测转染后m TOR蛋白的表达;流式细胞技术检测细胞周期和细胞凋亡情况;检测转染后PTEN蛋白的表达。结果转染组细胞的生长速度明显增快,而未转染组和转染空载体质粒组无明显变化。转染m TOR基因后,PTEN蛋白的表达明显下降。结论 m TOR可能通过PI3K/AKT/PTEN与m TOR信号转导通路负反馈调节PTEN的表达。m TOR的增高可促进乳腺癌细胞的生长,为m TOR的特异性的抑制剂的运用提供了理论证据。 Objective To investigate the effect of m TOR signal transduction pathway and down-regulating anti-oncogene PTEN on the growth of breast cancer MCF- 7 cells. Methods MCF- 7 cells were transfected with the eukaryotic expression plasmid pc DNA3.1-m TOR and non-loaded plasmid, and the expression of m TOR in the cells was detected using Western blotting. Flow cytometry was used to analyze apoptosis and cell cycle of the transfected cells, and the expression of PTEN was detected after transfection. Results The cells transfected with pc DNA3.1-m TOR showed a increased growth rate than those transfected with the non- loaded plasmid and those without transfection. The expression of the protein PTEN decreased obviously in the cells after m TOR trasnfection. Conclusion m TOR can regulate the expression of PTEN via PI3K/AKT/PTEN pathways through a negative feedback mechanism. Increased m TOR expression promotes MCF- 7 cell growth, suggesting the potential value of m TOR specific inhibitor in the treatment of breast cancer.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2015年第2期292-294,共3页 Journal of Southern Medical University
基金 广东省科技计划项目(2012B010300013)
关键词 MTOR 信号转导通路 乳腺癌 mTOR signal transduction pathway breast cancer cells
  • 相关文献

参考文献12

  • 1Lu J, Sun D, Gao S, et al.Cyclovirobuxin D induces Autophagy-Associated cell death via the Akt/mTOR pathway in MCF-7 humanbreast cancer cells[J].J pharmacol Sci, 2014, 125(1):74-82.
  • 2Eva Madrid.Targeting the PI3K/AKT/mTOR pathway in estrogenreceptor-positive breast cancer[J].Cancer Treat Rev, 2014, 14:44-7.
  • 3Jensen PB, Hunter T, Shah SA, et al.FRAP-p70s6K signaling isrequired for pancreatic cancer cell proliferation[J].J Surg Res,2001, 97:123-30.
  • 4Cantrell DA.Phosphoinositide3-kinase signalling pathways[J].JCell Sci, 2001, 114:1439-45.
  • 5Testa JR, Bellacosa A.Akt plays a central role in tumori-genesis[J].PNAS, 2001, 98:10983-5.
  • 6Mills GB, Lu YL, Kohn EC.Linking molecular therapeutics tomolecular diagnostics:Inhibition of the FRAP/RAFT/TORcomponent of the PI3K pathway preferentially blocks PTENmutant cells in vitro and in vivo[J].Proc Natl Acad Sci U S A, 2001,98(18):10031-3.
  • 7Grewe M, Gansauge F, Schmid RM, et al.Regulation of cell growthand cyclin D1 expression by the constitutively active FRAP-p70(s6K) pathway in human pancreatic Cancer cells[J].Cancer Res,1999, 59(15):3581-7.
  • 8Huang S, Liu LN, Hosoi H, et al.P53/p21cip1 cooperate inenforcing rapamycin induced G1 arrest and determine the cellularresponse to rapamycin[J].Cancer Res, 2001, 61:3373-81.
  • 9Kawasaki K, Smith RJ, Hsieh CM, et al.Activation of thephosphatidylinositol3-kinase/protein kinase Akt pathway mediatesnitric oxideinducedendothelial cell migration and angiogenesis[J].Mol Cell Biol, 2003, 23:5726-37.
  • 10Debnath J, Walker SJ, Brugge JS.Akt activation disrupts mammaryacinar architecture and enhance sproliferation in an mTORdependentmanner[J].J Cell Biol, 2003, 163:315–26.

同被引文献34

  • 1Schweigcrt M, I)ubecz A,Slein tlJ. ()esophageal cancer-an overviev, [ J ]. Nat Rev Gastn~enterol ltepato ,2013, 0 (4) :230 - 244.
  • 2Wilson Tit, Longley DB, Johnston PG. Chemoresistance in solidtumours [ J ]. Ann Onco1,2006,17 Suppl 10 : x315 - x324.
  • 3Chang D, Wang TY, Li HC, et al. Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China [ J ]. Dis Esophagus, 2007,20(6) :491 -496.
  • 4Milella M, Falcone I, Conciatori F, et al. PTEN : Multiple Functions in Human Malignant Tumors[J]. Front Oneol,2015 ,5 :24.
  • 5Wang F,Li T,Zhang B,et al. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN [ J]. Bio- chem Biophys Res Commun, 2013,434 ( 3 ) :688 - 694.
  • 6Pei H,Li L,Fridley BL,et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt [ J ]. Cancer Cell, 2009, 16(3) :259 -266.
  • 7Szak~tcs G, Annereau JP, Lababidi S, et al. Predicting drug sensitivity and resistance:profiling ABC transporter genes in cancer cells [ J ]. Cancer Ce11,2004,6 ( 2 ) : 129 - 137.
  • 8SzakOcs G, Paterson JK, Ludwig JA, et al. Targeting multidrug resist- ance in cancer [ J ]. Nat Rev Drug Diseov,2006,5 ( 3 ) :219 - 234.
  • 9Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link betweencancer genetics and chemotherapy[ J]. Cell ,2002,108 ( 2 ) : 153.
  • 10Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxic- ity associated with platinating agents [ J ]. Cancer Treat Rev,2007,33 (1) :9 -23.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部